Trend
DailyUptrend (confirmed)
4 hourSymmetric Triangle
1 hourBearish
15 minStrong Bearish
5 minConsolidating
Daily trend turns down below $11.52
Key levels
Resistance$16.59
Resistance$16.13
Support$15.52
Support$14.81
Latest news & SEC filings
EarningsPersonalis Posts Q3 2026 Results
EarningsPersonalis posts wider quarterly loss but revenue tops expectations
All PSNL news →Personalis sells genomic tests used in cancer care. Doctors use its offerings to find leftover or returning disease, gauge how tumors answer treatment, and pick therapies, while drug developers apply them in studies, biomarker work, and trial enrollment. The company also runs sequencing of exomes and full genomes for other labs and large population projects. It operates a laboratory in Fremont, California and sells across the United States, Europe, and Asia-Pacific.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
SEPT Low Target
$13.00
SEPT Mid Target
$16.25
SEPT High Target
$17.00
Analyst Consensus
$16.25
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PSNL.
Start Free Trial →Valuation Verdict
OVERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$13.60
16
Moat Score
NONE
4/9
Piotroski Score
9.2
Altman Z-Score
Insider Signal
SELLING
0 buys / 12 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Hall Christopher M | director officer | Sale | 29,112 | $462K | Nov 3, 2026 |
| Hall Christopher M | director officer | Sale | 7,459 | $121K | Sep 18, 2026 |
| Tachibana Aaron | officer | Sale | 2,931 | $48K | Sep 18, 2026 |
| Moore Stephen Michael | officer | Sale | 2,068 | $34K | Sep 18, 2026 |
| Chen Richard | officer | Sale | 3,998 | $65K | Sep 18, 2026 |
| Chen Richard | officer | Buy | 100,000 | $244K | Jul 15, 2026 |
| Chen Richard | officer | Sale | 100,000 | $1.5M | Jul 15, 2026 |
| Hall Christopher M | director officer | Buy | 100,000 | $161K | Jul 9, 2026 |
| Hall Christopher M | director officer | Sale | 100,000 | $1.5M | Jul 9, 2026 |
| Tachibana Aaron | officer | Buy | 4,982 | $27K | Jun 29, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
-17.7%
3yr Revenue CAGR
2.3%
EPS Growth YoY
33.58%
FCF Growth YoY
-69.9%
Revenue Trend
SLOWING
SEPT Investing tracks real-time dark pool institutional trades for PSNL, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:04:23 | $15.85 | 1,396 | $$22K | SELL |
| 21:01:04 | $15.86 | 1,912 | $$30K | SELL |
| 20:55:16 | $15.85 | 1,500 | $$24K | BUY |
| 20:55:16 | $15.85 | 3,200 | $$51K | BUY |
| 20:55:16 | $15.85 | 1,000 | $$16K | BUY |
5 dark pool trades shown · $$143K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT Investing provides real-time options flow tracking for PSNL, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $20 | Jan 15 | 64 | $$30 | 1 | SWEEP |
| CALL | $20 | Jan 15 | 64 | $$30 | 1 | SWEEP |
| CALL | $20 | Jan 15 | 64 | $$30 | 1 | SWEEP |
| CALL | $20 | Jan 15 | 64 | $$300 | 10 | SWEEP |
| CALL | $20 | Jan 15 | 64 | $$600 | 20 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for Personalis, Inc. (PSNL) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →Personalis, Inc. (PSNL) is at $15.86, down 0.63% (-$0.10) at the Nov 12, 2026 close.
Latest PSNL news — Nov 4, 2026: Personalis Posts Q3 2026 Results · Nov 4, 2026: Personalis posts wider quarterly loss but revenue tops expectations
The average analyst price target for PSNL is $16.25, ranging from $13 to $17, based on 4 analysts. Latest: Lake Street downgrade on Jul 20, 2026.
Analyst ratings for PSNL: 0 Buy, 7 Hold, 1 Sell — consensus Hold.
PSNL does not currently pay a dividend.
Support: $15.52, $14.81, $13.68. Resistance: $16.13, $16.59, $17.35.
Insider activity: SELLING, 0 buys and 12 sells in the last 90 days.
Nov 4, 2026: Personalis Posts Q3 2026 Results · Nov 4, 2026: Personalis posts wider quarterly loss but revenue tops expectations